Joint AAPM Task Group 282/EFOMP Working Group Report: Breast dosimetry for standard and contrast-enhanced mammography and breast tomosynthesis.

Currently, there are multiple breast dosimetry estimation methods for mammography and its variants in use throughout the world. This fact alone introduces uncertainty, since it is often impossible to distinguish which model is internally used by a specific imaging system. In addition, all current models are hampered by various limitations, in terms of overly simplified models of the breast and its composition, as well as simplistic models of the imaging system. Many of these simplifications were necessary, for the most part, due to the need to limit the computational cost of obtaining the required dose conversion coefficients decades ago, when these models were first implemented. With the advancements in computational power, and to address most of the known limitations of previous breast dosimetry methods, a new breast dosimetry method, based on new breast models, has been developed, implemented, and tested. This model, developed jointly by the American Association of Physicists in Medicine and the European Federation for Organizations of Medical Physics, is applicable to standard mammography, digital breast tomosynthesis, and their contrast-enhanced variants. In addition, it includes models of the breast in both the cranio-caudal and the medio-lateral oblique views. Special emphasis was placed on the breast and system models used being based on evidence, either by analysis of large sets of patient data or by performing measurements on imaging devices from a range of manufacturers. Due to the vast number of dose conversion coefficients resulting from the developed model, and the relative complexity of the calculations needed to apply it, a software program has been made available for download or online use, free of charge, to apply the developed breast dosimetry method. The program is available for download or it can be used directly online. A separate User's Guide is provided with the software.

Patient-derived heterogeneous breast phantoms for advanced dosimetry in mammography and tomosynthesis.

BACKGROUND: Understanding the magnitude and variability of the radiation dose absorbed by the breast fibroglandular tissue during mammography and digital breast tomosynthesis (DBT) is of paramount importance to assess risks versus benefits. Although homogeneous breast models have been proposed and used for decades for this purpose, they do not accurately reflect the actual heterogeneous distribution of the fibroglandular tissue in the breast, leading to biases in the estimation of dose from these modalities. PURPOSE: To develop and validate a method to generate patient-derived, heterogeneous digital breast phantoms for breast dosimetry in mammography and DBT. METHODS: The proposed phantoms were developed starting from patient-based models of compressed breasts, generated for multiple thicknesses and representing the two standard views acquired in mammography and DBT, that is, cranio-caudal (CC) and medio-lateral-oblique (MLO). Internally, the breast phantoms were defined as consisting of an adipose/fibroglandular tissue mixture, with a nonspatially uniform relative concentration. The parenchyma distributions were obtained from a previously described model based on patient breast computed tomography data that underwent simulated compression. Following these distributions, phantoms with any glandular fraction (1%-100%) and breast thickness (12-125 mm) can be generated, for both views. The phantoms were validated, in terms of their accuracy for average normalized glandular dose (Dg N) estimation across samples of patient breasts, using 88 patient-specific phantoms involving actual patient distribution of the fibroglandular tissue in the breast, and compared to that obtained using a homogeneous model similar to those currently used for breast dosimetry. RESULTS: The average Dg N estimated for the proposed phantoms was concordant with that absorbed by the patient-specific phantoms to within 5% (CC) and 4% (MLO). These Dg N estimates were over 30% lower than those estimated with the homogeneous models, which overestimated the average Dg N by 43% (CC), and 32% (MLO) compared to the patient-specific phantoms. CONCLUSIONS: The developed phantoms can be used for dosimetry simulations to improve the accuracy of dose estimates in mammography and DBT.

Deep learning reconstruction of digital breast tomosynthesis images for accurate breast density and patient-specific radiation dose estimation.

The two-dimensional nature of mammography makes estimation of the overall breast density challenging, and estimation of the true patient-specific radiation dose impossible. Digital breast tomosynthesis (DBT), a pseudo-3D technique, is now commonly used in breast cancer screening and diagnostics. Still, the severely limited 3rd dimension information in DBT has not been used, until now, to estimate the true breast density or the patient-specific dose. This study proposes a reconstruction algorithm for DBT based on deep learning specifically optimized for these tasks. The algorithm, which we name DBToR, is based on unrolling a proximal-dual optimization method. The proximal operators are replaced with convolutional neural networks and prior knowledge is included in the model. This extends previous work on a deep learning-based reconstruction model by providing both the primal and the dual blocks with breast thickness information, which is available in DBT. Training and testing of the model were performed using virtual patient phantoms from two different sources. Reconstruction performance, and accuracy in estimation of breast density and radiation dose, were estimated, showing high accuracy (density <±3%; dose <±20%) without bias, significantly improving on the current state-of-the-art. This work also lays the groundwork for developing a deep learning-based reconstruction algorithm for the task of image interpretation by radiologists.

Fibroglandular tissue distribution in the breast during mammography and tomosynthesis based on breast CT data: A patient-based characterization of the breast parenchyma.

PURPOSE: To develop a patient-based breast density model by characterizing the fibroglandular tissue distribution in patient breasts during compression for mammography and digital breast tomosynthesis (DBT) imaging. METHODS: In this prospective study, 88 breast images were acquired using a dedicated breast computed tomography (CT) system. The breasts in the images were classified into their three main tissue components and mechanically compressed to mimic the positioning for mammographic acquisition of the craniocaudal (CC) and mediolateral oblique (MLO) views. The resulting fibroglandular tissue distribution during these compressions was characterized by dividing the compressed breast volume into small regions, for which the median and the 25th and 75th percentile values of local fibroglandular density were obtained in the axial, coronal, and sagittal directions. The best fitting function, based on the likelihood method, for the median distribution was obtained in each direction. RESULTS: The fibroglandular tissue tends to concentrate toward the caudal (about 15% below the midline of the breast) and anterior regions of the breast, in both the CC- and MLO-view compressions. A symmetrical distribution was found in the MLO direction in the case of the CC-view compression, while a shift of about 12% toward the lateral direction was found in the MLO-view case. CONCLUSIONS: The location of the fibroglandular tissue in the breast under compression during mammography and DBT image acquisition is a major factor for determining the actual glandular dose imparted during these examinations. A more realistic model of the parenchyma in the compressed breast, based on patient image data, was developed. This improved model more accurately reflects the fibroglandular tissue spatial distribution that can be found in patient breasts, and therefore might aid in future studies involving radiation dose and/or cancer development risk estimation.

Radiochromic film dosimetry in synchrotron radiation breast computed tomography: a phantom study.

This study relates to the INFN project SYRMA-3D for in vivo phase-contrast breast computed tomography using the SYRMEP synchrotron radiation beamline at the ELETTRA facility in Trieste, Italy. This peculiar imaging technique uses a novel dosimetric approach with respect to the standard clinical procedure. In this study, optimization of the acquisition procedure was evaluated in terms of dose delivered to the breast. An offline dose monitoring method was also investigated using radiochromic film dosimetry. Various irradiation geometries have been investigated for scanning the prone patient's pendant breast, simulated by a 14 cm-diameter polymethylmethacrylate cylindrical phantom containing pieces of calibrated radiochromic film type XR-QA2. Films were inserted mid-plane in the phantom, as well as wrapped around its external surface, and irradiated at 38 keV, with an air kerma value that would produce an estimated mean glandular dose of 5 mGy for a 14 cm-diameter 50% glandular breast. Axial scans were performed over a full rotation or over 180°. The results point out that a scheme adopting a stepped rotation irradiation represents the best geometry to optimize the dose distribution to the breast. The feasibility of using a piece of calibrated radiochromic film wrapped around a suitable holder around the breast to monitor the scan dose offline is demonstrated.

Towards 4D dedicated breast CT perfusion imaging of cancer: development and validation of computer simulated images.

Dedicated breast CT is a fully tomographic breast imaging modality with potential for various applications throughout breast cancer care. If implemented to perform dynamic contrast-enhanced (CE) imaging (4D breast CT), it could be useful to obtain functional information at high combined spatio-temporal resolution. Before developing a 4D dedicated breast CT system, a computer simulation method for breast CT perfusion imaging is proposed. The simulation uses previously developed patient-based 4D digital breast phantoms, and generates realistic images with the selected acquisition parameters, allowing to investigate the effect of different acquisition settings on image quality. The simulation pipeline includes all steps of the image generation process, from ray tracing and scatter map generation, to the addition of realistic resolution losses and noise models. The pipeline was validated against experimental measurements performed on physical phantoms with a dedicated breast CT system, in terms of average error compared to ground truth projections (6.0% ± 1.65%), Hounsfield unit (HU) values in a homogeneous phantom (acquired: -149 HU ± 2 HU; simulated: -140 HU ± 2 HU), signal-to-noise ratio (SNR) (average error 6.7% ± 4.2%), noise power spectra (NPS) (average error 4.3% ± 2.5%), modulation transfer function (MTF) (average error 8.4% ± 7.2%), and attenuation of different adipose/glandular equivalent mixtures (average error 6.9% ± 4.0%) and glandular plus iodinated contrast medium concentrations equivalent mixtures (average error of 9.1% ± 9.0%). 4D patient images were then simulated for different 4D digital breast phantoms at different air kerma levels to determine the effect of noise on the extracted tumor perfusion curves. In conclusion, the proposed pipeline could simulate images with a good level of realism, resulting in a tool that can be used for the design, development, and optimization of a 4D dedicated breast CT system.

Image quality comparison between a phase-contrast synchrotron radiation breast CT and a clinical breast CT: a phantom based study.

In this study we compared the image quality of a synchrotron radiation (SR) breast computed tomography (BCT) system with a clinical BCT in terms of contrast-to-noise ratio (CNR), signal-to-noise ratio (SNR), noise power spectrum (NPS), spatial resolution and detail visibility. A breast phantom consisting of several slabs of breast-adipose equivalent material with different embedded targets (i.e., masses, fibers and calcifications) was used. Phantom images were acquired using a dedicated BCT system installed at the Radboud University Medical Center (Nijmegen, The Netherlands) and the SR BCT system at the SYRMEP beamline of Elettra SR facility (Trieste, Italy) based on a photon-counting detector. Images with the SR setup were acquired mimicking the clinical BCT conditions (i.e., energy of 30 keV and radiation dose of 6.5 mGy). Images were reconstructed with an isotropic cubic voxel of 273 µm for the clinical BCT, while for the SR setup two phase-retrieval (PhR) kernels (referred to as "smooth" and "sharp") were alternatively applied to each projection before tomographic reconstruction, with voxel size of 57 × 57 × 50 µm3. The CNR for the clinical BCT system can be up to 2-times higher than SR system, while the SNR can be 3-times lower than SR system, when the smooth PhR is used. The peak frequency of the NPS for the SR BCT is 2 to 4-times higher (0.9 mm-1 and 1.4 mm-1 with smooth and sharp PhR, respectively) than the clinical BCT (0.4 mm-1). The spatial resolution (MTF10%) was estimated to be 1.3 lp/mm for the clinical BCT, and 5.0 lp/mm and 6.7 lp/mm for the SR BCT with the smooth and sharp PhR, respectively. The smallest fiber visible in the SR BCT has a diameter of 0.15 mm, while for the clinical BCT is 0.41 mm. Calcification clusters with diameter of 0.13 mm are visible in the SR BCT, while the smallest diameter for the clinical BCT is 0.29 mm. As expected, the image quality of the SR BCT outperforms the clinical BCT system, providing images with higher spatial resolution and SNR, and with finer granularity. Nevertheless, this study assesses the image quality gap quantitatively, giving indications on the benefits associated with SR BCT and providing a benchmarking basis for its clinical implementation. In addition, SR-based studies can provide a gold-standard in terms of achievable image quality, constituting an upper-limit to the potential clinical development of a given technique.

Advancements towards the implementation of clinical phase-contrast breast computed tomography at Elettra.

Breast computed tomography (BCT) is an emerging application of X-ray tomography in radiological practice. A few clinical prototypes are under evaluation in hospitals and new systems are under development aiming at improving spatial and contrast resolution and reducing delivered dose. At the same time, synchrotron-radiation phase-contrast mammography has been demonstrated to offer substantial advantages when compared with conventional mammography. At Elettra, the Italian synchrotron radiation facility, a clinical program of phase-contrast BCT based on the free-space propagation approach is under development. In this paper, full-volume breast samples imaged with a beam energy of 32 keV delivering a mean glandular dose of 5 mGy are presented. The whole acquisition setup mimics a clinical study in order to evaluate its feasibility in terms of acquisition time and image quality. Acquisitions are performed using a high-resolution CdTe photon-counting detector and the projection data are processed via a phase-retrieval algorithm. Tomographic reconstructions are compared with conventional mammographic images acquired prior to surgery and with histologic examinations. Results indicate that BCT with monochromatic beam and free-space propagation phase-contrast imaging provide relevant three-dimensional insights of breast morphology at clinically acceptable doses and scan times.

Monte Carlo study on optimal breast voxel resolution for dosimetry estimates in digital breast tomosynthesis.

Digital breast tomosynthesis (DBT) is currently used as an adjunct technique to digital mammography (DM) for breast cancer imaging. Being a quasi-3D image, DBT is capable of providing depth information on the internal breast glandular tissue distribution, which may be enough to obtain an accurate patient-specific radiation dose estimate. However, for this, information regarding the location of the glandular tissue, especially in the vertical direction (i.e. x-ray source to detector), is needed. Therefore, a dedicated reconstruction algorithm designed to localize the amount of glandular tissue, rather than for optimal diagnostic value, could be desirable. Such a reconstruction algorithm, or, alternatively, a reconstructed DBT image classification algorithm, could benefit from the use of larger voxels, rather than the small sizes typically used for the diagnostic task. In addition, the Monte Carlo (MC) based dose estimates would be accelerated by the representation of the breast tissue with fewer and larger voxels. Therefore, in this study we investigate the optimal DBT reconstructed voxel size that allows accurate dose evaluations (i.e. within 5%) using a validated Geant4-based MC code. For this, sixty patient-based breast models, previously acquired using dedicated breast computed tomography (BCT) images, were deformed to reproduce the breast during compression under a given DBT scenario. Two re-binning approaches were applied to the compressed phantoms, leading to isotropic and anisotropic voxels of different volumes. MC DBT simulations were performed reproducing the acquisition geometry of a SIEMENS Mammomat Inspiration system. Results show that isotropic cubic voxels of 2.73 mm size provide a dose estimate accurate to within 5% for 51/60 patients, while a comparable accuracy is obtained with anisotropic voxels of dimension 5.46 × 5.46 × 2.73 mm3. In addition, the MC simulation time is reduced by more than half in respect to the original voxel dimension of 0.273 × 0.273 × 0.273 mm3 when either of the proposed re-binning approaches is used. No significant differences in the effect of binning on the dose estimates are observed (Wilcoxon-Mann-Whitney test, p-value > 0.4) between the 0° the 23° (i.e. the widest angular range) exposure.

Internal breast dosimetry in mammography: Monte Carlo validation in homogeneous and anthropomorphic breast phantoms with a clinical mammography system.

PURPOSE: To validate Monte Carlo (MC)-based breast dosimetry estimations using both a homogeneous and a 3D anthropomorphic breast phantom under polyenergetic irradiation for internal breast dosimetry purposes. METHODS: Experimental measurements were performed with a clinical digital mammography system (Mammomat Inspiration, Siemens Healthcare), using the x-ray spectrum selected by the automatic exposure control and a tube current-exposure time product of 360 mAs. A homogeneous 50% glandular breast phantom and a 3D anthropomorphic breast phantom were used to investigate the dose at different depths (range 0-4 cm with 1 cm steps) for the homogeneous case and at a depth of 2.25 cm for the anthropomorphic case. Local dose deposition was measured using thermoluminescent dosimeters (TLD), metal oxide semiconductor field-effect transistor dosimeters (MOSFET), and GafChromic™ films. A Geant4-based MC simulation was modified to match the clinical experimental setup. Thirty sensitive volumes (3.2 × 3.2 × 0.38 mm3 ) on the axial-phantom plane were included at each depth in the simulation to characterize the internal dose variation and compare it to the experimental TLD and MOSFET measurements. The experimental 2D dose maps obtained with the GafChromic™ films were compared to the simulated 2D dose distributions. RESULTS: Due to the energy dependence of the dosimeters and due to x-ray beam hardening, dosimeters based on these three technologies have to be calibrated at each depth of the phantom. As expected, the dose was found to decrease with increasing phantom depth, with the reduction being ~93% after 4 cm for the homogeneous breast phantom. The 2D dose map showed nonuniformities in the dose distribution in the axial plane of the phantom. The mean combined standard uncertainty increased with phantom depth by up to 5.3% for TLD, 6.3% for MOSFET, and 9.6% for GafChromic™ film. In the case of a heterogeneous phantom, the dosimeters are able to detect local dose gradient variations. In particular, GafChromic™ film showed local dose variations of about 46% at the boundaries of two materials. CONCLUSIONS: Results showed a good agreement between experimental measurements (with TLD and MOSFET) and MC data for both homogeneous and anthropomorphic breast phantoms. Larger discrepancies are found when comparing the GafChromic™ dose values to the MC results due to the inherent less precise nature of the former. MC validations in a heterogeneous background at the level of local dose deposition and in absolute terms play a fundamental role in the development of an accurate method to estimate radiation dose. The potential introduction of a breast dosimetry model involving a nonhomogeneous glandular/adipose tissue composition makes the validation of internal dose distributions estimates crucial.

Dose and diagnostic performance comparison between phase-contrast mammography with synchrotron radiation and digital mammography: a clinical study report.

Two dosimetric quantities [mean glandular dose (MGD) and entrance surface air kerma (ESAK)] and the diagnostic performance of phase-contrast mammography with synchrotron radiation (MSR) are compared to conventional digital mammography (DM). Seventy-one patients (age range, 41 to 82 years) underwent MSR after a DM examination if questionable or suspicious breast abnormalities were not clarified by ultrasonography. The MGD and the ESAK delivered in both examinations were evaluated and compared. Two on-site radiologists rated the images in consensus according to the Breast Imaging Reporting and Data System assessment categories, which were then correlated with the final diagnoses by means of statistical generalized linear models (GLMs). Receiver operating characteristic curves were also used to assess the diagnostic performance by comparing the area under the curve (AUC). An important MGD and ESAK reduction was observed in MSR due to the monoenergetic beam. In particular, an average 43% reduction was observed for the MGD and a reduction of more than 50% for the ESAK. GLM showed higher diagnostic accuracy, especially in terms of specificity, for MSR, confirmed by AUC analysis ([Formula: see text]). The study design implied that the population was characterized by a high prevalence of disease and that the radiologists, who read the DM images before referring the patient to MSR, could have been influenced in their assessments. Within these limitations, the use of synchrotron radiation with the phase-contrast technique applied to mammography showed an important dose reduction and a higher diagnostic accuracy compared with DM. These results could further encourage research on the translation of x-ray phase-contrast imaging into the clinics.

Internal breast dosimetry in mammography: Experimental methods and Monte Carlo validation with a monoenergetic x-ray beam.

PURPOSE: To investigate the performance, such as energy dependence and sensitivity, of thermoluminescent dosimeters (TLD), metal oxide semiconductor field-effect transistor dosimeters (MOSFET), and GafChromic™ films, and to validate the estimates of local dose deposition of a Monte Carlo (MC) simulation for breast dosimetry applications. METHODS: Experimental measurements were performed using a monoenergetic beam at the ELETTRA synchrotron radiation light source (Trieste, Italy). The three types of dosimeters were irradiated in a plane transversal to the beam axis and calibrated in terms of air kerma. The sensitivity of MOSFET dosimeters and GafChromic™ films was evaluated in the range of 18-28 keV. Three different calibration curves for the GafChromic™ films were tested (logarithmic, rational, and exponential functions) to evaluate the best-fit curve in the dose range of 1-20 mGy. Internal phantom dose measurements were performed at 20 keV for four different depths (range 0-3 cm, with 1 cm steps) using a homogeneous 50% glandular breast phantom. A GEANT4 MC simulation was modified to match the experimental setup. Thirty sensitive volumes, on the axial-phantom plane were included at each depth in the simulation to characterize the internal dose variation and compare it to the experimental TLD and MOSFET measurements. Experimental 2D dose maps were obtained with the GafChromic™ films and compared to the simulated 2D dose distributions estimated with the MC simulations. RESULTS: The sensitivity of the MOSFET dosimeters and GafChromic™ films increased with x-ray energy, by up to 37% and 48%, respectively. Dose-response curves for the GafChromic™ film result in an uncertainty lower than 5% above 6 mGy, when a logarithmic relationship is used in the dose range of 1-10 mGy. All experimental values fall within the experimental uncertainty and a good agreement (within 5%) is found against the MC simulation. The dose decreased with increasing phantom depth, with the reduction being ~80% after 3 cm. The uncertainty of the empirical measurements makes the experimental values compatible with a flat behavior across the phantom slab for all the investigated depths, while the MC points to a dose profile with a maximum toward the center of the phantom. CONCLUSIONS: The calibration procedures and the experimental methodologies proposed lead to good accuracy for internal breast dose estimation. In addition, these procedures can be successfully applied to validate MC codes for breast dosimetry at the local dose level. The agreement among the experimental and MC results not only shows the correctness of the empirical procedures used but also of the simulation parameters.